Amn Healthcare Services Inc. (AMN)
AMN Stock Gains Post Latest Deals With symplr to Boost Operations
AMN Healthcare sells Smart Square to symplr for $75 million and forms a new technology partnership aimed at boosting scheduling efficiency.
AMN Is Cheap After The Sale Of Symplr
AMN Healthcare is undervalued, trading below $900 million market cap, with strong free cash flow and recent strategic moves to reduce net debt. The sale of Symplr and board expertise in M&A position AMN for further portfolio optimization and potential value-unlocking transactions. Despite recent goodwill impairments and cautious analyst outlooks, AMN's financial initiatives and management actions could attract renewed investor interest.
What Makes AMN Healthcare (AMN) a New Buy Stock
AMN Healthcare (AMN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
AMN Healthcare: Demand For Therapy And Imaging Specialties, And Undervalued
AMN Healthcare is undervalued, trading at 3.02x FWD cash flow, with strong demand in therapy and imaging specialties supporting future growth. AI investments and normalization post-COVID-19 are expected to enhance service offerings and drive free cash flow improvements in the coming years. Debt reduction has lowered interest expenses, and a large stock repurchase program signals management's confidence in the company's intrinsic value.
AMN Stock Gains Following Q1 Earnings & Revenue Beat, Margins Down
AMN Healthcare's dismal results in all its segments led to a soft overall first-quarter 2025 performance.
AMN Healthcare Services, Inc. (AMN) Q1 2025 Earnings Call Transcript
AMN Healthcare Services, Inc. (NYSE:AMN ) Q1 2025 Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants Randle Reece - Senior Director of Investor Relations and Strategy Cary Grace - President and Chief Executive Officer Brian Scott - Chief Financial Officer and Chief Operating Officer Conference Call Participants Mark Marcon - Baird Trevor Romeo - William Blair A.J. Rice - UBS Meghan Holtz - Jefferies Joanna Gajuk - Bank of America Securities Tyler Barishaw - Truist Operator Good day, and thank you for standing by.
AMN Healthcare (AMN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for AMN Healthcare (AMN) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
AMN Healthcare Services (AMN) Beats Q1 Earnings and Revenue Estimates
AMN Healthcare Services (AMN) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.97 per share a year ago.
AMN Healthcare: Early Indicators Suggest A Rebound, It's A Buy Before Earnings
Early indicators from competitors and customers suggest a revenue beat in Q1 2025, and likely a bottom in the healthcare staffing market. HCA's spend on contract labor (which has moved in line with AMN's revenue for 4 of the last 5 quarters) came in at -10.5%, while analysts expect an 18% decline. AMN trades at a P/S ratio (0.26x) not seen since the GFC.
Will AMN Healthcare (AMN) Beat Estimates Again in Its Next Earnings Report?
AMN Healthcare (AMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
AMN Healthcare: Finding Stabilization
After a contextually positive Q4, shares continue to trade at an attractive valuation. Recent demand trends and commentary increasingly suggest demand is finding a stabilization point. Macro and M&A risks remain, but today's price offers an attractive IRR, all things considered.
AMN Healthcare: Telehealth Market And U.S. Age Demographics Imply Undervaluation
AMN Healthcare is poised for revenue growth due to new remote language interpretation systems and a shift in U.S. age demographics. The company's innovative solutions like WorkWise and ShiftWise Flex enhance efficiency, supporting robust financial performance and a higher target stock price. AMN benefits from the increasing number of insured individuals in the U.S., driving national healthcare expenditures and potential revenue growth.
